HysensBio is a biotechnology startup based in South Korea, founded in 2016. The company aims to revolutionize dental care with its groundbreaking technology focused on treating the most common dental diseases. Leveraging over 20 years of dental research, HysensBio has developed a first-in-class therapeutic approach to regenerate physiologic dentin and periodontal ligament, paving the way for new treatments in dental conditions such as dentin hypersensitivity, dental caries, and periodontal disease. With its innovative approach, HysensBio is set to open a new era in dental care. Currently, there is no information available about the company's last investment or its investors.
There is no investment information
No recent news or press coverage available for HysensBio.